Emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff, RF Kushner - … syndrome and obesity: targets and therapy, 2010 - Taylor & Francis
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …
被引用次数：47 相关文章
[PDF] psu.edu

[PDF][PDF] emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff - 2010 - Citeseer
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …

Emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff, RF Kushner - Diabetes, Metabolic Syndrome and Obesity, 2010 - dovepress.com
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …

Emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff, RF Kushner - Diabetes, Metabolic Syndrome and …, 2010 - search.proquest.com
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …
[PDF] friedmanfellows.com

[PDF][PDF] emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff - 2010 - friedmanfellows.com
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …
[HTML] nih.gov

[HTML][HTML] Emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff, RF Kushner - … syndrome and obesity: targets and therapy, 2010 - ncbi.nlm.nih.gov
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …

Emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff, RF Kushner - Diabetes, metabolic syndrome and …, 2010 - pubmed.ncbi.nlm.nih.gov
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …

Emerging role of GLP-1 receptor agonists in the treatment of obesity.

LM Neff, RF Kushner - … Syndrome and Obesity: Targets and Therapy, 2010 - europepmc.org
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …
[PDF] semanticscholar.org

[PDF][PDF] emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff - 2010 - pdfs.semanticscholar.org
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …
[PDF] archive.org

[PDF][PDF] emerging role of GLP-1 receptor agonists in the treatment of obesity

LM Neff - 2010 - scholar.archive.org
The prevalence of obesity has increased dramatically in recent decades, both in the US and
worldwide. Pharmacotherapy can augment the weight-reducing effects of lifestyle …